Princeton Global Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-235
Closed -$9.2K 649
2023
Q3
$9.2K Hold
235
﹤0.01% 418
2023
Q2
$9.55K Sell
235
-160
-41% -$6.58K ﹤0.01% 414
2023
Q1
$16.5K Hold
395
﹤0.01% 367
2022
Q4
$17K Hold
395
0.01% 342
2022
Q3
$15K Hold
395
0.01% 347
2022
Q2
$17K Hold
395
0.01% 346
2022
Q1
$18K Hold
395
0.01% 372
2021
Q4
$19K Buy
+395
New +$18.7K 0.01% 342

Other funds holding BME

Princeton Global Asset Management's BME Position: Q4 2023 in Review

Princeton Global Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 235 shares — an estimated $9.2K sold.

Princeton Global Asset Management first reported a position in BME in Q4 2021 and held it in 8 quarters. The position peaked at $19K in Q4 2021. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Princeton Global Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Princeton Global Asset Management sold 235 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $9.2K.
  • Princeton Global Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 8 quarters.
  • Princeton Global Asset Management's BlackRock Health Sciences Trust position peaked at $19K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Princeton Global Asset Management's 13F filing for Q4 2023, filed 22 Jan 2024.